Say hello to Marina Polo one of our summer interns this year. We are so happy to be able to work with these bright stars this summer! "I’m thrilled to join KI Innovations as a summer intern! Originally from Spain, I've navigated through various contexts within life sciences, including clinical trials and academic research. Last year, I decided to join the Master's in Bioentrepreneurship at Karolinska Institutet, driven by my interest in the intersection between science and business. During this journey, I realized that a consultancy role would allow me to apply my diverse background in real life cases. That's why the internship at KI Innovations AB felt like the perfect fit for me—I'm curious and excited to explore innovative ideas across different fields and I see it as a fun and creative opportunity to help entrepreneurs bring their ideas to market. Through this internship, I expect gaining insights into developing strategies to advance research from concept to reality. Last but not least, I am sure this role will bring me significant growth, and I am happy to embark on this experience with an amazing and interdisciplinary team of colleagues, as well as a warm welcome from the entire KI Innovations AB team." #entrepreneurship #innovation #startup #lifescience #summerintern
KI Innovations AB
Forskning
Solna, Stockholm County 6 874 följare
Vi vill skapa samhällsnytta ur LifeScience idéer för att förbättra framtidens hälsa.
Om oss
KI Innovations ABs uppdrag är att omvandla uppfinningar och innovationer från forskning till tjänster och produkter för att skapa värde för patienter och samhälle. Vi uppnår detta genom att göra det vi är bäst på: hjälper uppfinnaren att förfina sin affärsidé och göra det till en kommersiell produkt eller tjänst.
- Webbplats
-
http://karolinskainnovations.ki.se/
Extern länk för KI Innovations AB
- Bransch
- Forskning
- Företagsstorlek
- 11–50 anställda
- Huvudkontor
- Solna, Stockholm County
- Typ
- Publikt aktiebolag
- Specialistområden
- Innovation, uppfinning, forskning, affärscoaching och Life Science
Adresser
-
Primär
Nanna Svartz väg 2
vån 4
Solna, Stockholm County 171 65, SE
Anställda på KI Innovations AB
Uppdateringar
-
Say hello to our summer intern Johanna. We are happy to jet again have the opportunity to work with students from Karolinska Institutet during the summer. Johanna Kurzwelly is a medical doctor with background in business and marketing. She started her career in the startup ecosystem in Gothenburg, Sweden. Alongside her medical studies, she has gained experience in surgery, emergency psychiatry, intensive care, and primary care. Johanna has founded several initiatives in healthcare innovation and is currently part of the team for this summer's internship at KI Innovation, excited to learn together with her team and get to know the health tech and life science scene of Stockholm. Thank you for all your hard work. #kiinnovations #summerinterns #lifescience
-
-
Just a kind reminder that the application to our DRIVE incubator is still open. Take a look at our webpage for more specific information about requirements, time table and more. https://lnkd.in/d85qSM64 #incubator #startup #deeptech #kiinnovations #innovation
-
🌟 Fantastic news 🌟 Congratulations are in order for both Genovis and SEQURNA AB as this a perfect match. KI Innovations AB has had the privilege to work with Björn Reinius (CEO) and his team since 2021 both in the early phase, to explore the commercial potential in an RNA research reagent, and all the way to forming the company SEQURNA in 2022 as a spin-off from Björn Reinius’ lab at Karolinska Institutet when they entered the DRIVE incubator program. In parallel with entering the incubator, KI Holding made the first investment in the company. So yes, we are thrilled for this announcement and pleased to see research from KI contributing to the Swedish biotech industry. #innovation #startup #incubator #lifescience #genovis #sequrna #kiinnovations #kiholding
🌟 We are proud to announce that we today complete a strategic investment in SEQURNA AB, a developer of next-generation RNase inhibitors! 🌟 This strategic investment opens up for new product offerings to both existing and new customers, and facilitates the expansion into new application areas. We will utilize our distribution network to market and sell SEQURNA’s RNase inhibitors alongside our own catalogue of innovative tools for the biopharmaceutical and research industries! We look forward to continuing developing optimized workflows using Smart, efficient and reliable tools, and we are excited to add SEQURNA’s next-generation RNase inhibitors to our product portfolio! 🤩 Link to the press release: https://lnkd.in/d__Hste5 #genovis #news
-
-
Great News and congratulations to all 20 companies pitching in the Nordic Start 2024 pitch competition. We want to send special applause to our incubator company Countagen for securing a spot. Good luck Felix Neumann. We will be cheering you on! #kiinnovations #kisciencepark #innovation #lifescience #startup #funding #NLSDays
Meet the 20 selected #Nordic companies pitching at #NLSDays in the Nordic Star 2024 pitch competition! 🇸🇪 AKIRA Science 🇸🇪 Alder Therapeutics 🇸🇪 BrainLink Health 🇸🇪 BrainZell 🇳🇴 Bulbitech AS 🇸🇪 Countagen 🇩🇰 DECORADE Therapeutics 🇳🇴 DoMore Diagnostics 🇫🇮 Dora Health Ltd 🇩🇰 Droplet IV 🇫🇮 im.Engine 🇸🇪 Intelligent Implants, Ltd. 🇩🇰 Loma Therapeutics 🇩🇰 metaLead 🇸🇪 MyCural Therapeutics 🇸🇪 Paindrainer AB 🇩🇰 Pephexia Therapeutics ApS 🇩🇰 Probmet Therapeutics 🇸🇪 Rarity Bioscience 🇫🇮 Smart PD Solutions Ltd / Kiwecare Haven't registered yet? Don't miss the regular rate discount available until 30th June. Head over to https://lnkd.in/d_6sry-N and join us at the largest Nordic partnering event. See you in Malmö on 18-19 September! 👋🏻
-
Wow, so many fantastic companies that truly deserv the awards. Congratualtions to all of you! A special congratulations to Stratipath whom we have worked with and supported in the KI Innovations AB DRIVE Incubator for many years. It is always such a trill to see the hard work pay off. #innovation #lifescience #startup #incubator #kisciencepark #almedalen2024
🚀 The Moment We've All Been Waiting For! We are thrilled to reveal the winners from the Techarenan Challenge 2024! 🏆 Startup Company of the Year: Rebaba 🏆 Growth Company of the Year: Tandem Health 🏆 Audience Award: Hypertype 🏆 Social Impact Award: Cellfion 🏆 Industrial Award: Flower 🏆 Dream Award: Stratipath #TechArenanAlmedalen #Almedalen2024 #Startups #Innovation
-
-
Nu är det publikt! Vi är glada över att kunna berätta att vi på KI Innovations, inom ramen för Siish - snabbare implementering av innovation i svensk hälso- och sjukvård tillsammans med Cancerfonden utvecklat ett nytt finansieringsalternativ för att stötta implementering och av cancerrelaterade forskningsresultat! " Vi vill snabba på implementeringen av forskningsresultat i vården och öppnar därför tillsammans med Siish-projektet upp ett pilotprogram inom implementering av forskningsresultat riktat mot prevention och vårdvetenskap, hälsar representanter från Cancerfonden. Sista ansökningsdag är 15 augusti 2024 kl. 15:00. Läs mer nedan Enastående insatser från alla inblandade i projektet Siish - snabbare implementering av innovation i svensk hälso- och sjukvård: Cecilia Jädert Widblom, Frida Niss, Camilla Pettersson, Pialill Ring, Andreas Lundquist, Mats Falck, Kristian Wirsén, Cancerfonden och Uppsala University Innovation
-
Great news, great day and fantastic achivement. Launching the first product is a very big deal so congrats to you Mohamad Takwa and the very talented and dedicated team! "We are incredibly excited to share with the global scientific community our EpiFinder platform, a groundbreaking technology for epigenomic research, and to commercially launch EpiFinder Genome," said Epigenica CEO and co-founder Mohamad Takwa, PhD. "The development of these technologies has been a true labor of love for our team and marks an important milestone for Epigenica as we advance our mission to bring unprecedented scale, speed, and affordability to the rapidly growing field of epigenetics." We at KI Innovations AB are trilled for you, and we know firsthand how much hard work and dedication that lies behind this achievement. #innovation #lifescience #startup #epigenetics
Epigenica Unveils Breakthrough Epigenetics Platform, Launches First Commercial ChIP-seq Kit for High-throughput, Multiplex Genome-wide Profiling
prnewswire.com
-
Shout out to our KI Innovations AB community to SAVE this date, and to hopefylly see you at Campus Solna in October! So, welcome to the Stockholm-Uppsala Life Science Conference in Aula Medica, Karolinska Institutet, Campus Solna, on October 10, 2024! More information and registration will come shortly. We look forward to welcoming you to an event that celebrates the remarkable capacity and synergy of the Stockholm-Uppsala life science cluster and its potential to develop into a world leading environment.
Welcome to the Stockholm-Uppsala Life Science Conference
regionstockholm.se